Vasoactive intestinal polypeptide-secreting tumours: biology and therapy.
VIP-secreting tumours are rare, but they produce a dramatic clinical picture, the most prominent feature being profuse, watery diarrhoea and hypokalaemia. VIPomas are malignant and require sophisticated diagnostic and localization techniques in order to identify their presence. Delays in diagnosis are the rule rather than the exception. Improvements in the diagnosis of VIPomas appear to result in an increase in resectability rates. A definitive diagnosis is aided by the determination of plasma VIP concentrations through the use of sensitive radioimmunoassays. With heightened awareness of this syndrome, increasing numbers of patients can be identified and more effective treatments developed for the refractory and recurrent tumours.
Park
S K
SK
Department of Pediatrics, Ohio State University College of Medicine, Columbus 43210, USA.
O'Dorisio
M S
MS
O'Dorisio
T M
TM
D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D006801:Humans; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D009384:Paraneoplastic Endocrine Syndromes / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D011863:Radioimmunoassay; D016896:Treatment Outcome; D014660:Vasoactive Intestinal Peptide / Q000097:blood; D003969:Vipoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery
D014660:Vasoactive Intestinal Peptide